Carpmaels & Ransford
Gill has a multi-discipline practice which includes the fields of nanomaterials, graphene, polymer chemistry, industrial process chemistry, organometallic chemistry, materials and pharmaceutical chemistry. These competitive fields are, along with her pharmaceutical work, highly contentious in nature and a large part of Gill's portfolio involves handling opposition cases, in both attack and defence. Gill therefore has extensive experience in representing her clients in both ex- and inter-partes hearings before the European Patent Office. She has also supported a number of pan-European patent litigations on commercial pharmaceutical formulations with lead responsibility for technical arguments.
In the field of pharmaceutical chemistry, she has particular expertise in drafting, prosecuting and defending small molecule pharmaceutical cases, primarily for pharmaceutical originators. She has wide experience in the sector, advising the largest multi-national pharmaceutical companies, mid-caps and start-ups, including Janssen, Novartis, Vertex, Memorial Sloan Kettering, KalVista Pharmaceuticals Limited, Vantia Limited, Modern Biosciences, Aragon Pharmaceuticals, Inc., ITI Scotland Limited, Dart Neuroscience and Pain Therapeutics Inc.